Amy Quinlan

Amy Quinlan is an experienced finance professional with a robust background in the biopharmaceutical industry. Currently serving as VP of Finance at Voyager Therapeutics, Inc. since January 2025, Amy previously held the position of VP of Finance at Vor Biopharma from September 2020 to January 2025. Prior to that, Amy spent over a decade at TetraPhase Pharmaceuticals, culminating in the roles of VP and Senior Director of Finance. Earlier in the career, Amy held finance-related positions at Point Therapeutics, Inc., Ocean Spray Cranberries, MediaMap, and PwC, demonstrating a strong progression through various financial roles. Amy earned a Bachelor of Science in Financial Accounting from Bryant University, graduating in 1996.